Mostafa Zaalouk

Cardiology FIT🫀

[Abdulla A. Damluji, MD, PhD @DrDamluji]

Left Atrial Appendage Closure or Medical Therapy in Atrial Fibrillation: @NEJM

🥸 The controversy in LAA closure

😱 I summarized it before when it was presented at @AHAScience but here you go...

👇👇👇

[Mostafa Zaalouk @moustafareda3]

@ahmedawadmd Congrats Ahmed, best of luck man

[NEJM @NEJM]

Among patients with atrial fibrillation at high risk for stroke and bleeding, left atrial appendage closure was not noninferior to medical therapy in reducing the risk of stroke, embolism, major bleeding, or death at 3 years. Full CLOSURE-AF trial results: https://t.co/qAMC2o36Mi

Editorial: Left Atrial Appendage Closure — Another Overused Method in Cardiology? https://t.co/KyOWdblUR3

[Abdulla A. Damluji, MD, PhD @DrDamluji]

Trajectories of Angina After Initial Invasive vs Conservative Strategy for Chronic Coronary Disease: @JACCJournals

🥸"A greater proportion of conservatively managed patients experienced unfavorable angina,..., compared with those treated invasively.": @djc795

👇👇👇

[Mostafa Zaalouk @moustafareda3]

@AhmedMaraeyMD Best of luck isa and congrats for the little baby

[Mostafa Zaalouk @moustafareda3]

Very nice and well written paper

[Omar M. Abdelfattah, MD, FESC @AbdelfattahMD]

🚨🫀Our latest paper in @JACCJournals CR shows ASA & Mavacamten effectively relieve obstruction in patients with severe AS and oHCM. Check out our stepwise treatment algorithm in High 🗡️ Risk Case Series with concomitant oHCM & AS spearheaded by @mmartinezheart @RobynBrydeMD @morristownheart @utmbcardiology @docHJ

https://t.co/m7Ob0x4C7k

[JACC Journals @JACCJournals]

🚨 Not all shock is black or white. Mixed cardiogenic + vasodilatory shock is a different beast. Complex, lethal — and underrecognized.

Master this gray zone: https://t.co/eM60tKJwRm

@SarasVallabhMD @ddbergMD @ShashankSinhaMD #CriticalCare #CardiogenicShock #JACCAdvances

[American College of Cardiology @ACCinTouch]

The risk of incident HF after a #cvMI is up to six-fold higher than the risk of recurrent MI and the prognosis is worse among those who develop incident HF, regardless of #LVEF category.

Read more: https://t.co/GzY5n5SDxi #HeartFailure

[Gaurav A. Upadhyay, MD, FACC, FHRS @gauravaupadhyay]

Residents and fellows--please join us for an excellent intro to understanding pacemakers and ICDs! @NishantVermaMD https://t.co/m4LkZnk4zr

[Abdulla A. Damluji, MD, PhD @DrDamluji]

Vutrisiran in Patients with Transthyretin Amyloidosis with Cardiomyopathy: @NEJM

🥸 Vutrisiran is promising: congratulations to authors!

👇👇👇

[Ahmed Saleh, MD, FACC @AE__Saleh]

The TOMAHAWK trial: “These findings may shift the current understanding of both trials from a “neutral” towards a likely “harmful” effect of immediate coronary angiography after successfully resuscitated OHCA without ST-segment elevations”. https://t.co/KgbVhZi9NJ #Cardiology

[Mostafa Zaalouk @moustafareda3]

@AnasHashem6 Congrats Anas 🎉 very well deserved

[Mostafa Zaalouk @moustafareda3]

@mostafamorra1 كل سنه وانت طيب يا صديقي

[Mostafa Elghayesh @mostafamhmoud94]

2012, 2019, 2024 and the best is yet to come.

[Mostafa Zaalouk @moustafareda3]

@BhaskarArora_MD @ASE360 @OHSUCardFellows @iamritu If no coarctation, then PDA might be a reason. Another possibility if patient has AV fistula that can also be a cause of flow reversal.

[Davide Capodanno @DFCapodanno]

EARLY TAVR published. Among patients with asymptomatic severe aortic stenosis, a strategy of early TAVR was superior to clinical surveillance in reducing the incidence of death, stroke, or unplanned hospitalization for cardiovascular causes, driven by the latter. The study's findings may be limited by factors such as its unavoidable unblinded nature, trial-specific vigilance levels, low-risk patient selection, and use of a single valve type. #TCT2024
https://t.co/W1JsvkgrnT

[Abdulla A. Damluji, MD, PhD @DrDamluji]

Sudden cardiac death after myocardial infarction: @ESC_Journals

🥸 Of the 140,204 post MI patients, 1,326 (0.945%) developed sudden cardiac death.

😱 Can we predict those who developed sudden death with clinical variables including LVEF and MRI data?

👇👇👇

[Mohan Rao @MraoEP77]

Wishing our newest first year cardiology fellowship class the very best!

[Mohan Rao @MraoEP77]

Welcoming the RRH Cardiology fellowship class of 2027! Looking forward to 3 exciting years ahead!

[Mostafa Zaalouk @moustafareda3]

@waelAmansour @nymedcollege Congrats Wael 🙏